The Oshun Project: Speaking Justice to Reproductive Health

In this episode, I'll discuss Long Acting Reversible Contraception (LARC) devices, including the IUD and Nexplanon/Subdermal Implant. Join me as I discuss what the devices are, how they work, and what to expect when having them inserted. I'll also talk about how these devices have been and continue to be used for coercive methods.References to Check Out: Curtis KM, Nguyen AT, Tepper NK,et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2024. MMWRRecomm Rep 2024;73(No. RR-3):1–77. DOI: http://dx.doi.org/10.15585/mmwr.rr7303a1.Brandi K, Fuentes L. The history of tiered-effectivenesscontraceptive counseling and the importance of patient-centered family planningcare. Am J Obstet Gynecol. 2020 Apr;222(4S):S873-S877. doi:10.1016/j.ajog.2019.11.1271. Epub 2019 Nov 30. PMID: 31794724.Kaneshiro B, Kon Z, Tschann M, Williams A, Kajiwara K, SoonR. Meeting Women's Requests for Intrauterine Device and Contraceptive ImplantDiscontinuation: An Exploratory Survey of Physicians. Hawaii J Health Soc Welf.2020 Oct 1;79(10):296-301. PMID: 33047103; PMCID: PMC7547180.Biggs MA, Tome L, Mays A, Kaller S, Harper CC, Freedman L.The Fine Line Between Informing and Coercing: Community Health CenterClinicians' Approaches to Counseling Young People About IUDs. Perspect SexReprod Health. 2020 Dec;52(4):245-252. doi: 10.1363/psrh.12161. Epub 2020 Dec1. PMID: 33289277.Yi H, Zhang N, Huang J, et al. Association of levonorgestrel-releasingintrauterine device with gynecologic and breast cancers: a national cohortstudy in Sweden. Am J Obstet Gynecol 2024;231:450.e1-12. https://doi.org/10.1016/j.ajog.2024.05.011 https://www.guttmacher.org/gpr/2021/05/powerful-contraception-complicated-programs-preventing-coercive-promotion-long-acting For more information on birth control options: Bedsider.org FDA.gov  

Join me on a three-part series as we discuss contraception, aka birth control, options starting with how to counsel about contraception.

Listen in for reproductive health news updates and a discussion on self-managed abortion. For more information on the topic please check out the following resources: Grossman D, Verma N. Self-managed Abortion in the US. JAMA. 2022;328(17):1693–1694. doi:10.1001/jama.2022.19057 Ralph L, Foster DG, Raifman S, et al. Prevalence of Self-Managed Abortion Among Women of Reproductive Age in the United States. JAMA Netw Open. 2020;3(12):e2029245. doi:10.1001/jamanetworkopen.2020.29245 Aiken ARA, Starling JE, Scott JG, Gomperts R. Requests for Self-managed Medication Abortion Provided Using Online Telemedicine in 30 US States Before and After the Dobbs v Jackson Women’s Health Organization Decision. JAMA. 2022;328(17):1768–1770. doi:10.1001/jama.2022.18865 Resources mentioned in the episode: -Euki: https://eukiapp.org/ -AidAccess -Abortion on Demand -Women on Web -Plan C -Just the Pill -M&A (Miscarriage and Abortion) Hotline -SASS (Self-Managed abortion, Safe and Supported) -If/When/How

A discussion about medication abortion and the upcoming Supreme Court Case over the future of Mifepristone in the United States.

Join me as I talk about reproductive justice in honor of Black History Month and the amazing Black women who developed the concept. Then we'll talk about the Opill, the first over-the-counter hormonal birth control to be available in the United States, and Contraceptive Access. For more information on the topics in this episode please see the following: SisterSong: https://www.sistersong.net/   Power to Decide: https://powertodecide.org/what-we-do/contraceptive-deserts   Rice LW, Espey E, Fenner DE, Gregory KD, Askins J, Lockwood CJ. Universal access to contraception: women, families, and communities benefit. Am J Obstet Gynecol. 2020 Feb;222(2):150.e1-150.e5. doi: 10.1016/j.ajog.2019.09.014. Epub 2019 Sep 19. PMID: 31542250. benefit   ACOG Committee Opinion 615 Access to Contraception: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2015/01/access-to-contraception Sutton, M.Y. et al. (2021) ‘Racial and ethnic disparities in reproductive health services and outcomes, 2020’, Obstetrics & Gynecology, 137(2), pp. 225–233. doi:10.1097/aog.0000000000004224. Clare, C.A. et al. (2021) ‘Contraception utilization in black women via a reproductive justice lens’, Breastfeeding Medicine, 16(12), pp. 935–937. doi:10.1089/bfm.2020.0391. Troutman, M., Rafique, S. and Plowden, T.C. (2020) ‘Are higher unintended pregnancy rates among minorities a result of disparate access to contraception?’, Contraception and Reproductive Medicine, 5(1). doi:10.1186/s40834-020-00118-5. ACOG Committee Opinion 788-Over the Counter Access to Hormonal Contraception: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/10/over-the-counter-access-to-hormonal-contraception Freethepill.org   Grandi G, Del Savio MC, Facchinetti F. The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism. Expert Rev Clin Pharmacol. 2021 Feb;14(2):211-224. doi: 10.1080/17512433.2021.1878876. Epub 2021 Jan 26. PMID: 33464138.   KFF Women’s health Survey, Over The Counter Oral Contraceptive Pills: https://www.kff.org/womens-health-policy/issue-brief/over-the-counter-oral-contraceptive-pills/#:~:text=the%2DCounter%20Access-,The%20nationally%20representative%202022%20KFF%20Women's%20Health%20Survey%20found%20that,they%20would%20be%20likely%20to   FDA The O-Pill: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/opill-0075mg-oral-norgestrel-tablet-information   Grossman D, Fernandez L, Hopkins K, Amastae J, Garcia SG, Potter JE. Accuracy of self-screening for contraindications to combined oral contraceptive use. Obstet Gynecol. 2008 Sep;112(3):572-8. doi: 10.1097/AOG.0b013e31818345f0. PMID: 18757654; PMCID: PMC2615461.   Beat Provided By https://freebeats.io Produced By White Hot